Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$118.49

0.93 (0.79%)

06:43
10/18/16
10/18
06:43
10/18/16
06:43

Johnson & Johnson boosts FY16 adj. EPS view to $6.68-$6.73, consensus $6.69

Backs FY16 revenue guidance of $71.5B-$72.2B, consensus $72.08B.

  • 18

    Oct

  • 06

    Nov

JNJ Johnson & Johnson
$118.49

0.93 (0.79%)

08/24/16
JEFF
08/24/16
NO CHANGE
Target $210
JEFF
Buy
Cooper Companies estimates raised at Jefferies after doctor survey
Jefferies analyst Anthony Petrone reports that the firm's survey of 52 new optometry practices suggest continued gains in dailies and stable share in monthlies for Cooper Companies (COO) and that Johnson & Johnson's (JNJ) Acuvue Vita is off to slow start. Based on the survey results, and a "significant" foreign exchange tailwind, Petrone raised his estimates for Cooper and increased his price target on the shares to $210 from $190. The firm has a Buy rating on Cooper shares.
09/19/16
JEFF
09/19/16
NO CHANGE
Target $48
JEFF
Buy
Abbott unit sale does not impact Alere transaction, says Jefferies
Jefferies analyst Jeffrey Holford believes Abbott's (ABT) sale of its Medical Optics business to Johnson & Johnson (JNJ) does not imply an increased probability that the Alere (ALR) deal will close. After speaking to Abbott management, Holford thinks the proceeds from the sale are more likely to be targeted towards the St. Jude Medical (STJ) acquisition. He believes that deal has a higher probability of closing than Alere. Holford has a Buy rating on Abbott with a $48 price target.
09/19/16
LEER
09/19/16
NO CHANGE
LEER
Abbott, Johnson & Johnson transaction positive for both companies, says Leerink
Leerink analyst Danielle Antalffy says the sale of Abbott's (ABT) Medical Optics ophthalmology business to Johnson & Johnson (JNJ) is positive for both companies. The deal strengthens Abbott's balance sheet and eliminates the need for a previously expected $3B capital raise, and adds a key component to Johnson & Johnson's already-strong vision care franchise, the analyst notes.
10/07/16
RBCM
10/07/16
NO CHANGE
RBCM
Johnson & Johnson weakness creates buying opportunity, says RBC Capital
RBC Capital analyst Glenn Novarro says that Johnson & Johnson underperformed the market in Q3 due to a number of factors including Remicade biosimilar risk and the pharma pricing debate. The analyst says that "these concerns are manageable/overblown," and he expects the company to report strong Q3 results, driven by a strong pharma performance. Novoroo expects the company's Q3 revenue to come in slightly above expectations, and he predicts that the company will narrow its 2016 EPS guidance to the high end of the previous range. The analyst recommends buying the stock. He keeps a $133 price target and Outperform rating on the shares.

TODAY'S FREE FLY STORIES

PRSC

Providence Service

$38.39

1.1 (2.95%)

17:01
12/08/16
12/08
17:01
12/08/16
17:01
Hot Stocks
Providence Service CEO Herman Schwarz stepping down »

The Providence Service…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

MPO

Midstates Petroleum

$20.50

-0.45 (-2.15%)

17:01
12/08/16
12/08
17:01
12/08/16
17:01
Hot Stocks
Breaking Hot Stocks news story on Midstates Petroleum »

Man Group reports 5.75%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLTH

Duluth Holdings

$37.04

3.09 (9.10%)

16:58
12/08/16
12/08
16:58
12/08/16
16:58
Hot Stocks
Breaking Hot Stocks news story on Duluth Holdings »

Duluth Holdings down over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

CFR

Cullen/Frost

$88.38

1.92 (2.22%)

16:55
12/08/16
12/08
16:55
12/08/16
16:55
Syndicate
Breaking Syndicate news story on Cullen/Frost »

Cullen/Frost files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

DTEA

DAVIDsTEA

$9.30

0.15 (1.64%)

16:49
12/08/16
12/08
16:49
12/08/16
16:49
Hot Stocks
DAVIDsTEA appoints Christine Bullen interim president and CEO »

As previously announced,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

ISIL

Intersil

$22.25

0.05 (0.23%)

16:49
12/08/16
12/08
16:49
12/08/16
16:49
Hot Stocks
Intersil stockholders approve merger proposal with Renesas Electronics »

Intersil stockholders…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

DTEA

DAVIDsTEA

$9.30

0.15 (1.64%)

16:47
12/08/16
12/08
16:47
12/08/16
16:47
Earnings
DAVIDsTEA sees FY16 EPS C35c-C40c »

Sees FY16 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

TEL

TE Connectivity

$70.60

0.14 (0.20%)

16:45
12/08/16
12/08
16:45
12/08/16
16:45
Hot Stocks
TE Connectivity raises quarterly dividend to 40c per share from 37c »

TE Connectivity's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLTH

Duluth Holdings

$37.04

3.09 (9.10%)

16:41
12/08/16
12/08
16:41
12/08/16
16:41
Earnings
Duluth Holdings sees FY16 adjusted EBITDA $34M-$38M »

Seees FY16 GAAP EPS in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

16:39
12/08/16
12/08
16:39
12/08/16
16:39
General news
Fed Balance Sheet Level data reported »

Week of 12/7 Fed Balance…

16:39
12/08/16
12/08
16:39
12/08/16
16:39
General news
Money Supply M2 Weekly Change data reported »

Week of 11/28 Money…

ENZ

Enzo Biochem

$7.48

0.2 (2.75%)

, BDX

Becton Dickinson

$163.64

-0.35 (-0.21%)

16:38
12/08/16
12/08
16:38
12/08/16
16:38
Earnings
Enzo Biochem reports Q1 adjusted EPS (3c), one estimate (5c) »

Reports Q1 revenue…

ENZ

Enzo Biochem

$7.48

0.2 (2.75%)

BDX

Becton Dickinson

$163.64

-0.35 (-0.21%)

RHHBY

Roche

$27.08

-0.36 (-1.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CNS

Cohen & Steers

$37.23

0.48 (1.31%)

16:37
12/08/16
12/08
16:37
12/08/16
16:37
Hot Stocks
Cohen & Steers reports AUM of $56.5B as of November 30 »

Cohen & Steers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AWK

American Water

$73.05

0.39 (0.54%)

16:37
12/08/16
12/08
16:37
12/08/16
16:37
Hot Stocks
NJ American Water to invest $3.6M in Somerset County »

New Jersey American Water…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DEI

Douglas Emmett

$38.61

0.25 (0.65%)

16:34
12/08/16
12/08
16:34
12/08/16
16:34
Hot Stocks
Douglas Emmett increases quarterly cash dividend to 23c per share »

Douglas Emmett has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRIX

IRIDEX

$15.51

0.61 (4.09%)

16:34
12/08/16
12/08
16:34
12/08/16
16:34
Syndicate
IRIDEX announces offering of common stock, no amount given »

IRIDEX expects to use the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BURL

Burlington Stores

$88.47

0.47 (0.53%)

, BLK

BlackRock

$390.33

12.81 (3.39%)

16:33
12/08/16
12/08
16:33
12/08/16
16:33
Hot Stocks
Frank Cooper III resigns from Burlington Stores board of directors »

Burlington Stores (BURL)…

BURL

Burlington Stores

$88.47

0.47 (0.53%)

BLK

BlackRock

$390.33

12.81 (3.39%)

TJX

TJX

$77.98

-0.21 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STBZ

State Bank Financial

$26.90

0.51 (1.93%)

16:33
12/08/16
12/08
16:33
12/08/16
16:33
Hot Stocks
State Bank Financial reports FDIC approval for previously announced transaction »

State Bank Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MED

Medifast

$40.65

0.86 (2.16%)

16:32
12/08/16
12/08
16:32
12/08/16
16:32
Hot Stocks
Medifast raises quarterly dividend 28% to 32c per share »

Medifast announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

BEN

Franklin Resources

$42.02

1.4 (3.45%)

16:32
12/08/16
12/08
16:32
12/08/16
16:32
Hot Stocks
Franklin Resources reports month-end AUM of $714.4B »

Franklin Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APPY

Venaxis

$3.95

-0.28 (-6.62%)

16:32
12/08/16
12/08
16:32
12/08/16
16:32
Hot Stocks
Venaxis changing name and NASDAQ ticker symbol »

Venaxis has changed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECL

Ecolab

$119.61

0.8 (0.67%)

16:31
12/08/16
12/08
16:31
12/08/16
16:31
Hot Stocks
Ecolab raises quarterly dividend 6% to 37c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

16:30
12/08/16
12/08
16:30
12/08/16
16:30
Options
Preliminary option volume of 19.3M today »

Preliminary option volume…

BBRY

BlackBerry

$7.83

0.2 (2.62%)

16:27
12/08/16
12/08
16:27
12/08/16
16:27
Hot Stocks
BlackBerry unveils mobile-security platform for the enterprise of things »

BlackBerry unveiled its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

MCC

Medley Capital

16:25
12/08/16
12/08
16:25
12/08/16
16:25
Earnings
Medley Capital reports Q4 EPS 23c, consensus 22c »

Reports Q4 net asset…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.